Episode Details
Back to Episodes
Pharmaceutical Executive Daily: Pfizer's Stock Drops Following 2026 Revenue Projections Release
Published 5 months ago
Description
In today’s Pharmaceutical Executive Daily, Pfizer discloses its 2026 revenue expectations, a bipartisan group of House Republicans moves to force a vote on extending ACA tax credits, and new collaboration and merger activity highlights continued dealmaking momentum across biopharma.